The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 26, 2021

Filed:

Oct. 10, 2014
Applicant:

University of Florida Research Foundation, Inc., Gainesville, FL (US);

Inventor:

Janet K. Yamamoto, Gainesville, FL (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/21 (2006.01); A61K 39/12 (2006.01); A61K 39/295 (2006.01); C07K 14/16 (2006.01); C12Q 1/70 (2006.01); G01N 33/569 (2006.01); G01N 33/68 (2006.01); C07K 14/155 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/21 (2013.01); A61K 39/12 (2013.01); A61K 39/295 (2013.01); C07K 14/161 (2013.01); A61K 2039/575 (2013.01); A61K 2039/58 (2013.01); A61K 2039/70 (2013.01); C07K 14/155 (2013.01); C07K 14/162 (2013.01); C12N 2740/15011 (2013.01); C12N 2740/15022 (2013.01); C12N 2740/15034 (2013.01); C12N 2740/16111 (2013.01); C12N 2740/16122 (2013.01); C12N 2740/16134 (2013.01); C12N 2740/16211 (2013.01); C12N 2740/16222 (2013.01); C12N 2740/16234 (2013.01); C12Q 1/702 (2013.01); G01N 33/56983 (2013.01); G01N 33/56988 (2013.01); G01N 33/6854 (2013.01); G01N 2333/155 (2013.01); G01N 2469/20 (2013.01);
Abstract

The subject invention pertains to materials and methods for detecting, preventing and treating retroviral infections in humans and other animals susceptible to infection by retrovirus. It has been discovered that FIV can be transmitted from cats to humans and that the FIV can infect human cells in vivo and that antibodies generated by the infected person cross-react with HIV antigens. Thus, the methods and compositions of the subject invention can be used to detect, prevent and treat FIV infection in humans and other non-feline animals that are susceptible to FIV infection. The methods and compositions of the invention can also be used to prevent and treat infection by HIV in humans.


Find Patent Forward Citations

Yamamoto, Janet. (2021). Immunogenic compositions comprising fiv and hiv gag antigens (U.S. Patent No. 11154610). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11154610

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…